Amneal Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03168L1052

SecurityAMRX / Amneal Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership577,419 shares
Latest Disclosed Value $ 7,177,318
Citadel Advisors Llc ownership in AMRX / Amneal Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 577,419 shares of Amneal Pharmaceuticals, Inc. (US:AMRX) valued at $7,177,318 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 6,175,737 shares of Amneal Pharmaceuticals, Inc.. This represents a change in shares of -90.65% during the quarter. The current value of the position is $7,939,511 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (AMRX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 42,000 of underlying shares valued at $522,060 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AMRX / Amneal Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 577,419 -5,598,318 -90.65 7,177 -90.78 0.0010
2026-02-17 2025-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 6,175,737 446,438 7.79 77,814 35.68 0.0117
2025-11-14 2025-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 5,729,299 104,617 1.86 57,350 26.04 0.0087
2025-08-14 2025-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 5,624,682 -1,867,347 -24.92 45,504 -27.52 0.0079
2025-05-15 2025-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 7,492,029 -1,488,939 -16.58 62,783 -11.73 0.0119
2025-02-14 2024-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 8,980,968 88,675 1.00 71,129 -3.86 0.0123
2024-11-14 2024-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 8,892,293 -1,096,432 -10.98 73,984 16.64 0.0143
2024-08-14 2024-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 9,988,725 4,921,242 97.11 63,428 106.55 0.0128
2024-05-15 2024-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 5,067,483 -1,429,607 -22.00 30,709 -22.13 0.0059
2024-02-14 2023-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 6,497,090 3,808,360 141.64 39,437 247.59 0.0079
2023-11-14 2023-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 2,688,730 1,493,222 124.90 11,346 206.15 0.0024
2023-08-14 2023-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,195,508 160,305 15.49 3,706 157.72 0.0008
2023-05-15 2023-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,035,203 345,449 50.08 1,439 4.81 0.0003
2023-02-14 2022-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 689,754 -956,839 -58.11 1,373 -58.76 0.0003
2022-11-14 2022-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,646,593 212,703 14.83 3,327 -27.04 0.0008
2022-08-15 2022-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,433,890 -31,230 -2.13 4,560 -25.37 0.0012
2022-05-16 2022-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,465,120 -130,827 -8.20 6,110 -20.08 0.0013
2022-02-14 2021-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,595,947 435,040 37.47 7,645 23.33 0.0016
2021-11-15 2021-09-30 13F AMNEAL PHARMACEUTICALS Cmn 03168L105 1,160,907 534,969 85.47 6,199 93.42 0.0013
2021-08-16 2021-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 625,938 5,423 0.87 3,205 -23.25 0.0007
2021-05-21 2021-03-31 13F/A-1 AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 620,515 -859,409 -58.07 4,176 -38.25 0.0010
2021-05-17 2021-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 620,515 -859,409 4,176 0.0010
2021-02-16 2020-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,479,924 172,597 13.20 6,763 33.31 0.0018
2020-11-16 2020-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,307,327 717,014 121.46 5,073 80.53 0.0014
2020-08-14 2020-06-30 13F AMNEAL PHARMACEUTICALS Cmn 03168L105 590,313 238,737 67.90 2,810 129.58 0.0010
2020-05-15 2020-03-31 13F AMNEAL PHARMACEUTICALS Cmn 03168L105 351,576 -87,734 -19.97 1,224 -42.18 0.0006
2020-02-14 2019-12-31 13F AMNEAL PHARMACEUTICALS Cmn 03168L105 439,310 -210,945 -32.44 2,117 12.25 0.0009
2019-11-14 2019-09-30 13F AMNEAL PHARMACEUTICALS Cmn 03168L105 650,255 73,904 12.82 1,886 -54.36 0.0009
2019-08-14 2019-06-30 13F AMNEAL PHARMACEUTICALS Cmn 03168L105 576,351 576,351 4,132 0.0019
2018-11-13 2018-09-30 13F AMNEAL PHARMACEUTICALS Cmn 03168L105 0 -604,634 -100.00 0 -100.00
2018-08-14 2018-06-30 13F/A-1 AMNEAL PHARMACEUTICALS Cmn 03168L105 604,634 604,634 9,922 0.0049
2018-08-10 2018-06-30 13F AMNEAL PHARMACEUTICALS Cmn 03168L105 604,634 9,922 0.0049
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 23,400 -77.35 234 -71.98 n/a n/a n/a
2025-08-14 2025-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 103,300 87.82 836 81.52 n/a n/a n/a
2025-05-15 2025-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 55,000 9,066.67 461 11,400.00 n/a n/a n/a
2025-02-14 2024-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 600 -93.62 5 -94.87 n/a n/a n/a
2024-11-14 2024-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 9,400 -10.48 78 18.18 n/a n/a n/a
2024-08-14 2024-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 10,500 3,400.00 67 6,500.00 n/a n/a n/a
2024-05-15 2024-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 300 -95.45 2 -97.50 n/a n/a n/a
2024-02-14 2023-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 6,600 -20.48 40 14.29 n/a n/a n/a
2023-11-14 2023-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 8,300 40.68 35 94.44 n/a n/a n/a
2023-08-14 2023-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 5,900 -71.36 18 -35.71 n/a n/a n/a
2023-05-15 2023-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 20,600 -5.07 29 -34.88 n/a n/a n/a
2023-02-14 2022-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 21,700 -61.39 43 -62.28 n/a n/a n/a
2022-11-14 2022-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 56,200 -3.77 114 -38.71 n/a n/a n/a
2022-08-15 2022-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 58,400 59.13 186 21.57 n/a n/a n/a
2022-05-16 2022-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 36,700 105.03 153 77.91 n/a n/a n/a
2022-02-14 2021-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 17,900 -69.81 86 -72.87 n/a n/a n/a
2021-11-15 2021-09-30 13F AMNEAL PHARMACEUTICALS Cmn Call 59,300 268.32 317 286.59 n/a n/a n/a
2021-08-16 2021-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 16,100 1.90 82 -22.64 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AMNEAL PHARMACEUTICALS COM STK CL A Call 15,800 -77.62 106 -67.18 n/a n/a n/a
2021-05-17 2021-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 15,800 106 n/a n/a n/a
2021-02-16 2020-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 70,600 108.88 323 146.56 n/a n/a n/a
2020-11-16 2020-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 33,800 4.00 131 -15.48 n/a n/a n/a
2020-08-14 2020-06-30 13F AMNEAL PHARMACEUTICALS Cmn Call 32,500 127.27 155 210.00 n/a n/a n/a
2020-05-15 2020-03-31 13F AMNEAL PHARMACEUTICALS Cmn Call 14,300 -55.17 50 -78.17 n/a n/a n/a
2019-08-14 2019-06-30 13F AMNEAL PHARMACEUTICALS Cmn Call 31,900 229 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 42,000 522 n/a n/a n/a
2025-11-14 2025-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 11,900 -77.25 96 -78.08 n/a n/a n/a
2025-05-15 2025-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 52,300 -10.90 438 -5.60 n/a n/a n/a
2025-02-14 2024-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 58,700 2,568.18 465 2,477.78 n/a n/a n/a
2024-11-14 2024-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 2,200 -18.52 18 5.88 n/a n/a n/a
2024-08-14 2024-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 2,700 -83.54 17 -82.83 n/a n/a n/a
2024-05-15 2024-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 16,400 7.89 99 7.61 n/a n/a n/a
2024-02-14 2023-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 15,200 744.44 92 1,214.29 n/a n/a n/a
2023-11-14 2023-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 1,800 -62.50 8 -50.00 n/a n/a n/a
2023-08-14 2023-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 4,800 -14.29 15 100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 5,600 -63.64 8 -76.67 n/a n/a n/a
2023-02-14 2022-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 15,400 31 n/a n/a n/a
2022-08-15 2022-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 70,800 -16.51 295 -27.34 n/a n/a n/a
2022-02-14 2021-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 84,800 267.10 406 230.08 n/a n/a n/a
2021-11-15 2021-09-30 13F AMNEAL PHARMACEUTICALS Cmn Put 23,100 -51.88 123 -50.00 n/a n/a n/a
2021-08-16 2021-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 48,000 247.83 246 164.52 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AMNEAL PHARMACEUTICALS COM STK CL A Put 13,800 -36.99 93 -7.00 n/a n/a n/a
2021-05-17 2021-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 13,800 93 n/a n/a n/a
2021-02-16 2020-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 21,900 24.43 100 47.06 n/a n/a n/a
2020-11-16 2020-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 17,600 -74.31 68 -79.14 n/a n/a n/a
2020-08-14 2020-06-30 13F AMNEAL PHARMACEUTICALS Cmn Put 68,500 97.98 326 171.67 n/a n/a n/a
2020-05-15 2020-03-31 13F AMNEAL PHARMACEUTICALS Cmn Put 34,600 -10.36 120 -35.48 n/a n/a n/a
2020-02-14 2019-12-31 13F AMNEAL PHARMACEUTICALS Cmn Put 38,600 11.24 186 84.16 n/a n/a n/a
2019-11-14 2019-09-30 13F AMNEAL PHARMACEUTICALS Cmn Put 34,700 101 n/a n/a n/a
2019-08-14 2019-06-30 13F AMNEAL PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F AMNEAL PHARMACEUTICALS Cmn Put 13,000 184 n/a n/a n/a
2019-02-14 2018-12-31 13F AMNEAL PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F AMNEAL PHARMACEUTICALS Cmn Put 10,500 233 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.